BSE: STAR - Strides Pharma Science Limited

Rentabilität für sechs Monate: -27.91%

Aktionsplan Strides Pharma Science Limited

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

weitere details
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

EBITDA 3.77
EV/EBITDA 12.02
ISIN INE939A01011
Industry Pharmaceuticals
P/BV 1.06
P/E 75.66
P/S 1.02
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 27.07
Див.доход ао 0
Дивиденд ао 1.5
Сайт https://www.strides.com
Цена ао 1324.6
Число акций ао 0.0903 млрд
Preisänderung pro Tag: +0.4362% (676.3)
Preisänderung pro Woche: -0.738% (684.3)
Preisänderung pro Monat: -55.54% (1527.7)
Preisänderung über 3 Monate: -51.81% (1409.6)
Preisänderung über sechs Monate: -27.91% (942.2)
Preisänderung pro Jahr: +5.8% (642)
Preisänderung über 3 Jahre: +62.44% (418.15)
Preisänderung über 5 Jahre: +75.79% (386.4)
Preisänderung über 10 Jahre: 0% (679.25)
Preisänderung seit Jahresbeginn: -1.6% (690.3)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Gesamt: 5.5

Effizienz

Name Bedeutung Grad
ROA, % -1.13 0
ROE, % -3.26 0
Gesamt: 0.6667

Dividenden

Name Bedeutung Grad
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Gesamt: 1.79

Pflicht

Name Bedeutung Grad
Debt/EBITDA 11.07 0
Gesamt: 5.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 49.63 6
Rentabilität Ebitda, % -46.65 0
Rentabilität EPS, % -289.02 0
Gesamt: 3.2
Weitere Details

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 Jahr)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 Jahr)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 Jahre)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 Jahre)

Adresse: India, Bengaluru, Strides House - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.strides.com